Characterizing patients prescribed resmetirom for noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in a real world setting: A United States cohort study of the Forian database

Poster Presentation

File size: 1.09 MB
Created: 06-05-2025
Updated: 06-05-2025
Hits: 6
Download Preview

© Madrigal Pharmaceuticals, Inc. All rights reserved.
MED-AT-MGL-3196-2300027

Go to Top